Zenpep approved for exocrine pancreatic insufficiency (EPI) - MPR
Links shared publicly online about this topic.
- 1,783total visits
Zenpep approved for exocrine pancreatic insufficiency (EPI) - MPR
empr.com —
View full resource at empr.com
Tags: Pancreatic Disease, Cystic Fibrosis, FDA, News
Most Recently Shared on August 31, 2009 at 8:35 pm By:
MPR News: Zenpep approved for exocrine pancreatic insufficiency (EPI): The FDA has approved Zenpep (pan.. http://bit.ly/45RlgT
FDA clears Eurand's pancreatic enzyme drug Zenpep - Related Stories - AAP SmartBrief
smartbrief.com — “Eurand in Amsterdam gained FDA approval for its lead product, pancreatic enzyme drug Zenpep, for children age 1 and older as well as adults. The treatment, which is indicated for exocrine pancreatic insufficiency, will be available in four dosages in the U.S. next quarter. <a href='/servlet/aaRedire” View full resource at smartbrief.com
Most Recently Shared on September 1, 2009 at 3:02 am By:
FDA clears Eurand's pancreatic enzyme drug Zenpep http://sbne.ws/r/2FrT
Eurand Granted FDA Approval for Zenpep
drugs.com — “Zenpep (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Zenpep side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 29, 2009 at 7:33 pm By:
Advertisement

